Ep. 203 Active Surveillance: A Data Driven Approach with Dr. Dan Lin

Recent research is changing how we manage low risk prostate cancer. In this BackTable Urology Podcast episode, Dr. Dan Lin, a urologist at the University of Washington, walks through contemporary diagnosis, surveillance, and management of Grade Group 2 prostate cancer with host Dr. Aditya Bagrodia. --- This podcast is supported by: Veracyte https://www.veracyte.com/decipher --- SYNPOSIS The doctors delve into real-world implementation of active surveillance, alongside the use of advanced diagnostics, biopsy methods, and personalized care plans. The conversation highlights the Canary Prostate Active Surveillance Study (PASS) and the prognostic role of biomarkers and genomic testing. Dr. Lin and Dr. Bagrodia also discuss how lifestyle factors such as diet impact cancer progression and how patients can be empowered to manage their disease. Strategies for transitioning patients off surveillance are highlighted. Finally, the two experts discuss insights from recent clinical trials like PIVOT, PROTECT, and SPCG and how they’re impacting prostate cancer management. --- TIMESTAMPS 00:00 - Introduction 02:54 - Active Surveillance and Canary PASS Data 12:02 - Biopsy Considerations 19:44 - Active Surveillance Protocols 26:58 - Patient Concerns and Risk Reduction 30:52 - Transitioning Off Surveillance 33:39 - Grade Group 2: Treatment vs. Monitoring 46:24 - Surgical Considerations and Node Dissection 49:25 - Future Directions --- RESOURCES Veracyte https://www.veracyte.com/

There are no comments yet.

Please log in to write the first comment.